Written evidence

 

Written evidence

The Committee has issued the following letters, requesting written evidence. The Committee has also requested a series of submissions from the Scottish Government, which can be read on the correspondence section of the Committee's webpage.

Letters were also sent to civil servants involved in Government processes, requesting a chronological account of their actions. The wording of this letter can be found below:

The Committee sought further written evidence from the Scottish National Party on 9 September 2020:
Letter from the Convener to Peter Murrell, 9 September 2020

    Written evidence received

     

    Written submission from PCS

    Written submission from Prospect

    Further written submission from Prospect

    Written submission from FDA

    Annex A to FDA's written submission

    Annex B to FDA's written submission

    Annex C to FDA's written submission

    Annex D to FDA's written submission

    Written submission from Sir John Elvidge, former Permanent Secretary

    Written submission from Sir Peter Housden, former Permanent Secretary

    Written submission from Peter Murrell, Chief Executive, Scottish National Party

    Written submission from James Hamilton, Independent Adviser on the Scottish Ministerial Code

    Written submission from Liz Lloyd, Chief of Staff to the First Minister

    Written submission from Nicola Sturgeon MSP

    Written submission from John Swinney MSP

    Additional written submission from Peter Murrell, Chief Executive, Scottish National Party

    Written submission from the Lord Advocate (this submission was previously published as an annexe to Committee papers for the meeting on 8 September 2020)

    Written evidence received following oral evidence sessions

     

    Written submission from Nicola Richards following the evidence session on 25 August 2020 (447KB pdf)

    Written submission from James Hynd following the evidence session on 25 August 2020 (127KB pdf)

    Further written submission received from FDA following the evidence session on 1 September 2020 (154KB pdf)

    Written submission from Leslie Evans following the evidence session on 8 September 2020 (355KB pdf)

    Written submission from Barbara Allison following the evidence session on 15 September 2020 (147KB pdf)

    Further written submission from Barbara Allison following the evidence session on 15 September 2020 (140KB pdf)

     

     
    This website is using cookies.
    We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website.